Peripheral neuropathy
MONDO:0005244A disorder affecting the peripheral nervous system. It manifests with pain, tingling, numbness, and muscle weakness. It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs.
Also known as: neuropathy, peripheral nerve disorder, peripheral neuropathy
1469 clinical trials for this condition and its sub-types, 93 tagged with Peripheral neuropathy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Peripheral neuropathy
-
Hereditary peripheral neuropathy 6 trials · 478 incl. sub-types
65 sub-types
- Carpal tunnel syndrome 165 trials Sub-types →
- Charcot-Marie-Tooth disease 51 trials · 77 incl. sub-types Sub-types →
- Familial amyloid neuropathy 52 trials · 54 incl. sub-types Sub-types →
- Hereditary sensory and autonomic neuropathy 52 trials · 54 incl. sub-types Sub-types →
- Proximal spinal muscular atrophy 14 trials · 42 incl. sub-types Sub-types →
- Metachromatic leukodystrophy 20 trials Sub-types →
- Krabbe disease 15 trials Sub-types →
- Sandhoff disease 13 trials Sub-types →
- Tay-Sachs disease 13 trials Sub-types →
- Chediak-Higashi syndrome 9 trials
- Leigh syndrome 9 trials Sub-types →
- Peroxisome biogenesis disorder 4 trials · 8 incl. sub-types Sub-types →
- Adrenomyeloneuropathy 7 trials
- Cerebrotendinous xanthomatosis 6 trials
- Kearns-Sayre syndrome 5 trials
- Distal hereditary motor neuropathy 0 trials · 4 incl. sub-types Sub-types →
- Hereditary neuropathy with liability to pressure palsies 4 trials
- Mitochondrial neurogastrointestinal encephalomyopathy 4 trials Sub-types →
- Ornithine aminotransferase deficiency 4 trials
- Pyruvate dehydrogenase deficiency 2 trials · 4 incl. sub-types Sub-types →
- NARP syndrome 3 trials
- Biotinidase deficiency 3 trials
- Coenzyme Q10 deficiency 3 trials Sub-types →
- Giant axonal neuropathy 2 trials · 3 incl. sub-types Sub-types →
- Hereditary motor and sensory neuropathy 3 trials Sub-types →
- Methylmalonic aciduria and homocystinuria type cblC 3 trials
- Mitochondrial DNA depletion syndrome 4a 3 trials
- Abetalipoproteinemia 2 trials
- Fumaric aciduria 2 trials
- Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 2 trials
- Niemann-Pick disease type B 1 trial
- PRPS1 deficiency disorder 1 trial
- Adult polyglucosan body disease 1 trial
- Familial isolated deficiency of vitamin E 1 trial
- Homocystinuria due to methylene tetrahydrofolate reductase deficiency 1 trial
- Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency 1 trial
- Neuropathy, congenital hypomelinating 0 trials · 1 incl. sub-types Sub-types →
- Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis 1 trial Sub-types →
- Charcot-Marie-Tooth disease type 5 0 trials
- EMILIN-1-related connective tissue disease 0 trials
- Finnish type amyloidosis 0 trials
- PHARC syndrome 0 trials
- VPS13A-related neurodegenerative disease 0 trials
- Amyotrophic neuralgia 0 trials
- Ataxia - oculomotor apraxia type 4 0 trials
- Attenuated Chédiak-Higashi syndrome 0 trials
- Beta-mannosidosis 0 trials
- Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome 0 trials
- Congenital trigeminal anesthesia 0 trials
- Familial episodic pain syndrome 0 trials Sub-types →
- Familial recurrent peripheral facial palsy 0 trials
- Hereditary motor and sensory neuropathy, Okinawa type 0 trials Sub-types →
- Hereditary sensory and autonomic neuropathy with spastic paraplegia 0 trials
- Infantile axonal neuropathy 0 trials
- Meralgia paraesthetica, familial 0 trials
- Neurodegeneration with brain iron accumulation 2A 0 trials
- Neuropathy with hearing impairment 0 trials
- Neuropathy, hereditary sensory and autonomic, type IId 0 trials
- Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy 0 trials
- Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome 0 trials
- Oxoglutaricaciduria 0 trials
- Peripheral motor neuropathy, childhood-onset, biotin-responsive 0 trials
- Primary CD59 deficiency 0 trials
- Progressive demyelinating neuropathy with bilateral striatal necrosis 0 trials
- Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1 0 trials
-
Neuralgia 238 trials · 383 incl. sub-types
5 sub-types
- Sciatica 46 trials · 68 incl. sub-types Sub-types →
- Cranial neuralgia 0 trials · 53 incl. sub-types Sub-types →
- Post-infectious neuralgia 0 trials · 33 incl. sub-types Sub-types →
- Pudendal neuralgia 9 trials
- Familial episodic pain syndrome 0 trials Sub-types →
-
Nerve compression syndrome 24 trials · 207 incl. sub-types
3 sub-types
- Carpal tunnel syndrome 165 trials Sub-types →
- Piriformis syndrome 25 trials
- Meralgia paresthetica 5 trials Sub-types →
-
Diabetic neuropathy 181 trials · 192 incl. sub-types
2 sub-types
- Diabetic polyneuropathy 50 trials
- Diabetic autonomic neuropathy 7 trials
-
Chemotherapy-induced neuropathy 171 trials
-
Polyneuropathy 32 trials · 132 incl. sub-types
10 sub-types
- Polyradiculoneuropathy 1 trial · 64 incl. sub-types Sub-types →
- Chronic polyneuropathy 0 trials · 62 incl. sub-types Sub-types →
- Demyelinating polyneuropathy 2 trials · 62 incl. sub-types Sub-types →
- Critical illness polyneuropathy 39 trials
- Polyneuritis 3 trials
- Toxic polyneuropathy 1 trial · 3 incl. sub-types Sub-types →
- Idiopathic progressive polyneuropathy 0 trials
- Organophosphate-induced delayed polyneuropathy 0 trials
- Paraneoplastic polyneuropathy 0 trials
- Polyneuropathy in collagen vascular disease 0 trials
-
Mononeuropathy 4 trials · 111 incl. sub-types
7 sub-types
- Sciatic neuropathy 9 trials · 72 incl. sub-types Sub-types →
- Ulnar neuropathy 7 trials · 21 incl. sub-types Sub-types →
- Peroneal neuropathy 9 trials
- Femoral neuropathy 7 trials
- Radial neuropathy 1 trial Sub-types →
- Tibial neuropathy 0 trials · 1 incl. sub-types Sub-types →
- Mononeuritis simplex 0 trials Sub-types →
-
Acquired peripheral neuropathy 0 trials · 95 incl. sub-types
12 sub-types
- Cranial neuralgia 0 trials · 53 incl. sub-types Sub-types →
- Multifocal motor neuropathy 9 trials
- Pudendal neuralgia 9 trials
- POEMS syndrome 8 trials
- Polyneuropathy associated with IgM monoclonal gammapathy with anti-MAG 8 trials
- Non-recovering obstetric brachial plexus lesion 6 trials
- Anterior cutaneous nerve entrapment syndrome 2 trials
- Radiation-induced plexopathy 1 trial
- CANOMAD syndrome 0 trials
- Axonal polyneuropathy associated with IgG/IgM/IgA monoclonal gammopathy 0 trials
- Neuralgic amyotrophy 0 trials
- Simple cryoglobulinemia 0 trials
-
Nerve plexus disorder 0 trials · 75 incl. sub-types
4 sub-types
- Brachial plexus neuropathy 13 trials · 72 incl. sub-types Sub-types →
- Lumbosacral plexus lesion 0 trials · 2 incl. sub-types Sub-types →
- Radiation-induced plexopathy 1 trial
- Nerve plexus neoplasm 0 trials Sub-types →
-
Sensory peripheral neuropathy 4 trials · 58 incl. sub-types
1 sub-type
- Hereditary sensory and autonomic neuropathy 52 trials · 54 incl. sub-types Sub-types →
-
Traumatic neuropathy 55 trials
-
Neuritis 18 trials · 29 incl. sub-types
7 sub-types
- Vestibular neuronitis 9 trials
- Polyneuritis 3 trials
- Brachial plexus neuritis 0 trials Sub-types →
- Mononeuritis simplex 0 trials Sub-types →
- Motor nerve neuritis 0 trials Sub-types →
- Neuritis of upper limb 0 trials Sub-types →
- Neuroretinitis 0 trials
-
Peripheral nerve lesion 1 trial · 12 incl. sub-types
4 sub-types
- Femoral neuropathy 7 trials
- Lesion of sciatic nerve 2 trials Sub-types →
- Ulnar nerve lesion 2 trials
- Radial nerve lesion 0 trials
-
Autonomic neuropathy 7 trials · 10 incl. sub-types
2 sub-types
- Diabetic autonomic neuropathy 7 trials
- Horner syndrome 0 trials Sub-types →
-
Chronic idiopathic neuropathy 5 trials
-
Neuropathy, small fiber 4 trials
-
Axonal neuropathy 1 trial · 4 incl. sub-types
3 sub-types
- Giant axonal neuropathy 2 trials · 3 incl. sub-types Sub-types →
- Congenital axonal neuropathy with encephalopathy 0 trials
- Infantile axonal neuropathy 0 trials
-
Infectious neuropathy 2 trials
-
Vasculitic neuropathy 2 trials
-
Autoimmune neuropathy 1 trial
-
Ischemic neuropathy 1 trial
-
Sarcoid neuropathy 1 trial
-
Motor peripheral neuropathy 0 trials · 1 incl. sub-types
9 sub-types
- Charcot-Marie-Tooth disease axonal type 2C 1 trial
- Charcot-Marie-Tooth disease type 4G 0 trials
- Charcot-Marie-Tooth disease type 5 0 trials
- Glossopharyngeal motor neuropathy 0 trials
- Hereditary motor and sensory neuropathy, Okinawa type 0 trials Sub-types →
- Motor nerve neuritis 0 trials Sub-types →
- Neuropathy, hereditary motor and sensory, type 6A 0 trials
- Neuropathy, hereditary motor and sensory, type 6B 0 trials
- Peripheral motor neuropathy, childhood-onset, biotin-responsive 0 trials
-
Radiation-induced neuropathy 0 trials · 1 incl. sub-types
1 sub-type
- Radiation-induced plexopathy 1 trial
-
Idiopathic small fibers neuropathy 0 trials
-
Neuropathy in cryoglobulinemia 0 trials
-
Neuropathy in endocrine disorder 0 trials
-
Uremic neuropathy 0 trials
Most studied deeper sub-types
-
One-Shot gene therapy aims to restore movement in children with SMA
Cure By invitation onlyResearchers test GCB-001, a gene therapy given as a single injection into the spinal fluid, in children aged 2 to 12 with type 2 spinal muscular atrophy who can sit alone but cannot walk. The trial checks safety and whether the treatment improves motor skills over 12 months. It i…
Sponsor: Genecombio Ltd. • Aim: Cure
Last updated Sep 13, 2026 00:00 UTC
-
New drug riliprubart tested for Long-Term control of nerve disease CIDP
Disease control By invitation onlyThis study is a long-term extension of earlier trials testing the drug riliprubart in adults with CIDP, a condition where the immune system attacks the nerves, causing weakness and numbness. About 300 participants who completed a prior riliprubart study will continue receiving th…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New gel fusion technique aims to speed nerve repair after traumatic arm injuries
Disease control OngoingThis study tests whether a substance called polyethylene glycol (PEG) can help reconnect severed nerves in the arm more effectively than standard surgery. About 40 adults with a recent, complete nerve injury from trauma will receive either PEG plus standard repair or standard rep…
Phase 2 • Sponsor: Major Extremity Trauma Research Consortium • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Could a short pill course save hand function in advanced MS?
Disease control OngoingThis UK trial tests whether cladribine tablets, taken for just 8-10 days a year over two years, can slow the loss of hand function in people with advanced multiple sclerosis (MS). The study includes 204 participants with significant disability (EDSS 6.5-8.5). Half receive cladrib…
Phase 2/3 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a muscle-boosting antibody help people with spinal muscular atrophy over the long haul?
Disease control OngoingThis trial tests the long-term safety and effectiveness of apitegromab, an investigational antibody that blocks myostatin, a protein that limits muscle growth. People with type 2 or type 3 spinal muscular atrophy who completed earlier apitegromab studies can join. Researchers wil…
Phase 3 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a common mineral boost the power of Pain-Relieving injections for nerve pain?
Disease control OngoingThis study compares two routine epidural steroid injection protocols for adults with chronic neck and arm pain from cervical disc herniation. One group receives the standard injection with lidocaine, dexamethasone, and saline, while the other adds magnesium sulfate. Researchers w…
Sponsor: Marmara University • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Could a common mineral slow Parkinson's? new trial begins
Disease control By invitation onlyThis study is testing whether low-dose lithium aspartate, a dietary supplement, can slow the progression of Parkinson's disease. It involves 35 people who have already completed a lithium trial, and they will take lithium for another 24 weeks. Researchers will use brain scans and…
Phase 1/2 • Sponsor: State University of New York at Buffalo • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Shockwave boost: a new combo for stubborn buttock pain?
Disease control By invitation onlyThis trial compares two non-surgical approaches for deep gluteal syndrome, a condition where the sciatic nerve gets irritated in the buttock area, causing pain and limited movement. About 44 adults aged 25 to 45 will be split into two groups: one receives nerve gliding exercises …
Sponsor: University of Management and Technology Sialkot Pakistan • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Bionic leg feedback: can a neuroprosthesis bring back sensation for amputees?
Disease control OngoingThis study tests a sensory neuroprosthesis—implanted electrodes that send small electrical currents to remaining nerves—to restore sensation of a missing lower limb in people with diabetic peripheral neuropathy and amputation. The 15 participants will also have the option of musc…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
One-Patient trial hopes to fix rare nerve disease at its genetic root
Disease control OngoingThis study tests a custom-made drug (VCA-894A) in a single person with a rare genetic nerve disease called CMT2S. The drug is designed to correct a specific genetic error and restore a missing protein. The main goals are to check if the treatment is safe and if it can improve mus…
Phase 1/2 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New pill could slow MS relapses and disability
Disease control OngoingThis Phase 3 trial tests whether the oral drug remibrutinib works better than teriflunomide at reducing relapses and slowing disability in people with relapsing multiple sclerosis. About 1,000 adults aged 18–55 with active MS are taking part. The study is double-blind, meaning ne…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New pill could tame MS relapses
Disease control OngoingThis Phase 3 trial tests remibrutinib, an oral tablet, against teriflunomide in 1000 adults with relapsing multiple sclerosis. The goal is to see if remibrutinib better reduces yearly relapse rates and delays disability. Participants will then have the option to continue remibrut…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New drug could reduce need for infusions in nerve disorder
Disease control OngoingThis Phase 2 trial tests a drug called claseprubart (DNTH103) in 36 adults with multifocal motor neuropathy, a rare nerve condition that causes muscle weakness. Participants receive either the drug or a placebo for 15 weeks. The study looks at safety, how the drug works in the bo…
Phase 2 • Sponsor: Dianthus Therapeutics • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New hope for tough nerve disease: experimental drug riliprubart enters final testing
Disease control OngoingThis study tests a drug called riliprubart in 140 adults with chronic inflammatory demyelinating polyneuropathy (CIDP) that hasn't improved with standard care. Participants receive either riliprubart or a placebo for up to 111 weeks. The main goal is to see if the drug reduces di…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can video games help injured Babies' arms? new study tests VR therapy
Disease control By invitation onlyThis study compares two rehabilitation approaches—virtual reality exercises and motor-cognitive dual-task training—in 14 children aged 7-14 with brachial plexus birth injury, a condition where arm nerves are damaged during birth. Each child will do their assigned program for 12 w…
Sponsor: Istanbul Aydın University • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a One-Time gene injection halt nerve damage in CMT1A?
Disease control CancelledThis trial tests a one-time gene therapy injection for people with Charcot-Marie-Tooth disease type 1A (CMT1A), a genetic nerve disorder that causes progressive muscle weakness. The therapy delivers a gene that produces a protein to support nerve health. Three adults aged 18 to 3…
Phase 1/2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Promising new pill for rare childhood brain diseases enters final testing
Disease control OngoingThis study tests an oral drug called nizubaglustat in children and teens with rare genetic disorders (GM1, GM2 gangliosidosis) that damage the brain and nerves. The goal is to see if the drug can slow disease progression and improve movement and coordination. About 75 participant…
Phase 3 • Sponsor: Azafaros B.V. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New drug combo takes on deadly brain tumors
Disease control OngoingThis early-stage study tests an experimental drug called AZD1390 combined with radiation therapy for people with glioblastoma or brain metastases. The main goal is to check safety and find the best dose. About 180 participants will receive different doses of AZD1390 alongside rad…
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Experimental gene therapy aims to halt devastating brain disease in infants
Disease control PausedThis study tests a gene therapy called PBKR03 for babies with early infantile Krabbe disease, a severe genetic disorder that damages the brain and nerves. The treatment delivers a working copy of the GALC gene to the brain and body. Researchers will check safety and find the best…
Phase 1/2 • Sponsor: Gemma Biotherapeutics • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Stem cell transplant offers new hope for kids with rare immune diseases
Disease control OngoingThis study tests a donor stem cell transplant for people with severe immune system problems, like SCID and Wiskott-Aldrich syndrome. The goal is to help the body make healthy blood cells and fight infections. Participants receive donated stem cells to rebuild their immune system.…
Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a common MS drug help people with a rare nerve disease walk better?
Disease control OngoingThis clinical trial is testing whether dimethyl fumarate, a drug already used for multiple sclerosis, can improve balance and walking in adults with adrenomyeloneuropathy (AMN), a rare nerve disease. Forty participants will take either the drug or a placebo daily for 36 months, w…
Phase 2/3 • Sponsor: Pujol, Aurora, M.D. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a drug stop amyloid damage after a heart transplant?
Disease control OngoingThis study tests whether the drug tafamidis can safely stop the progression of ATTR amyloidosis in people who have already received a heart transplant. About 25 stable patients will take tafamidis daily for 12 months. Researchers will measure changes in blood protein levels, nerv…
Phase 4 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Gene therapy after stem cell transplant shows promise for rare brain disease
Disease control OngoingThis study tests a one-time gene therapy infusion (FBX-101) given after a standard stem cell transplant in 6 children with infantile Krabbe disease, a severe genetic disorder affecting the nervous system. The therapy uses a harmless virus to deliver a working copy of the GALC gen…
Phase 1/2 • Sponsor: Forge Biologics, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Gut feeling: personalized bacteria may ease PTSD symptoms
Disease control OngoingThis study looks at whether giving people with PTSD a personalized mix of gut bacteria (called pharmabiotics) can help their mental health. The researchers will track changes in PTSD symptoms, anxiety, depression, and thinking skills over 14 days. The goal is to see if fixing the…
Sponsor: Uzhhorod National University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug shows promise for SMA patients in major trial
Disease control OngoingThis study tests whether adding taldefgrobep alfa to standard SMA treatments can improve muscle function in people with spinal muscular atrophy (SMA). About 269 participants, both walkers and non-walkers, will receive either the drug or a placebo for 48 weeks. The main goal is to…
Phase 3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Gene therapy hope for SMA kids: early trial launches
Disease control OngoingThis early-stage trial tests a new gene therapy called NKG001 in 21 children under 5 with spinal muscular atrophy (SMA). The therapy is given as a single dose, either through a vein or combined with a spinal injection. The main goal is to check safety and find the best dose, not …
Sponsor: Nikegen Pharmaceutical (Hangzhou) Company Limited • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Promising drug for rare nerve disease trial pulled before start
Disease control CancelledThis study was designed to test whether the drug govorestat could improve symptoms of Charcot-Marie-Tooth disease caused by sorbitol dehydrogenase deficiency (CMT-SORD), a rare nerve condition. It planned to enroll people aged 16 to 65 and compare govorestat to a placebo over 36 …
Phase 3 • Sponsor: Applied Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for stubborn nerve disorder: drug combo shows promise
Disease control OngoingThis study tests whether adding telitacicept to standard therapy helps adults with refractory chronic inflammatory demyelinating polyneuropathy (CIDP), a nerve condition that causes weakness and numbness. About 76 participants will receive either standard care alone or standard c…
Sponsor: Sichuan Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New drug aims to replace IVIg for nerve disease
Disease control OngoingThis study tests if a new drug, empasiprubart, works as well as standard IVIg treatment for adults with multifocal motor neuropathy (MMN), a condition that causes muscle weakness. About 154 people who have responded to IVIg in the past will be randomly assigned to receive either …
Phase 3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Exercise after nerve surgery: hope for arm recovery, but trial pulled
Disease control CancelledThis study was designed to test whether a daily handgrip exercise program could speed up nerve regrowth and restore muscle and bone after brachial plexus injury surgery. It planned to enroll adults aged 18–60 with confirmed nerve damage. However, the trial was withdrawn before an…
Phase 2 • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug combo aims to ease nerve pain in rare blood disorder
Disease control OngoingThis phase 2 trial tests whether the drug zanubrutinib, combined with standard rituximab, can improve nerve damage and disability in people with a rare blood condition called IgM MGUS. The study includes 35 adults across two Dutch hospitals. Participants take zanubrutinib daily f…
Phase 2 • Sponsor: UMC Utrecht • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Early access to experimental SMA drug apitegromab offered before approval
Disease control Expanded access (ended)This expanded access program provides apitegromab, an experimental drug that blocks myostatin to help maintain muscle strength, to eligible patients with spinal muscular atrophy (SMA) before it is officially approved. Participants must be at least 2 years old and have a confirmed…
Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Cancer drug shows promise for rare blood vessel disorders in kids and young adults
Disease control OngoingThis study tests the drug alpelisib, already approved for some breast cancers, in people aged 2 months to 30 years with certain blood vessel growth disorders caused by PIK3CA or TIE2 gene changes. Participants take the drug for 2-3 years and attend up to 16 clinic visits to check…
Phase 2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug mimics natural protein to calm overactive immune system in nerve disease
Disease control OngoingThis Phase 2 trial is testing a new drug called NVG-2089 in 60 adults with chronic inflammatory demyelinating polyneuropathy (CIDP), a condition where the immune system attacks nerves. The drug is designed to mimic a natural protein (IVIg) to reduce inflammation and improve nerve…
Phase 2 • Sponsor: Nuvig Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Last chance access: vatiquinone for mitochondrial disease patients
Disease control Expanded access (ended)This program offered vatiquinone, an experimental liquid medication, to patients with inherited mitochondrial diseases like Leigh syndrome who had already completed a previous safety study. The goal was to continue treatment for those who might benefit, but enrollment is now clos…
Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Fish oil and Aspirin-Like drug may ease diabetic nerve pain
Disease control OngoingThis early study tests whether fish oil, alone or with salsalate (an anti-inflammatory drug), can improve blood markers linked to nerve health in people with type 2 diabetes and diabetic neuropathy. About 100 adults will take fish oil capsules for 4 months, then add salsalate for…
Phase 1/2 • Sponsor: University of Iowa • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New drug shows promise for stubborn cancers
Disease control OngoingThis study tests a new drug called 9-ING-41, given alone or with chemotherapy, in adults with cancers that have not responded to standard treatments. The goal is to see if the drug is safe and can help control the disease. About 350 people with various advanced cancers, including…
Phase 2 • Sponsor: Actuate Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Could a common drug help kids with rare leigh syndrome?
Disease control By invitation onlyThis study tests the drug sirolimus (rapamycin) in 15 people aged 6 months to 55 years with genetically confirmed Leigh syndrome, a rare and serious mitochondrial disease. The goal is to see if the drug is safe and can help with symptoms like muscle weakness and developmental del…
Phase 2 • Sponsor: Matthew Demczko • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New pill shows promise for Hard-to-Treat blood cancers
Disease control PausedThis study tests an oral drug called emavusertib (CA-4948) in adults with acute myeloid leukemia (AML) or a high-risk bone marrow disorder (MDS) that have not responded to or returned after prior treatment. The goal is to find the safest and most effective dose and to see if the …
Phase 1/2 • Sponsor: Curis, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Painless eye drops could save sight in kids with brain tumors
Disease control OngoingThis study tests a new painless nerve growth factor eye drop (CHF6467) in 36 children and young adults with optic pathway glioma, a brain tumor that often causes vision loss. The goal is to see if the drops can protect or improve vision without the pain side effects of standard n…
Phase 2 • Sponsor: Benedetto Falsini • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Can intensive therapy boost motor skills in kids with SMA?
Disease control OngoingThis pilot study tests whether combining intensive hand-arm and leg therapy with strength training can improve motor function in children with spinal muscular atrophy (SMA). Five children will attend one 6-hour session each weekend for 15 weeks. Researchers will check if the ther…
Sponsor: Teachers College, Columbia University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug aims to keep rare nerve disease in check long-term
Disease control OngoingThis study is a long-term follow-up for people with multifocal motor neuropathy, a rare condition that causes muscle weakness. It tests the safety and effectiveness of a drug called ARGX-117, given intravenously. The trial includes 51 adults who previously took part in an earlier…
Phase 2 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New surgical technique aims to restore hand pinch after nerve injury
Disease control OngoingThis study tests a surgical procedure that moves two tendons in the forearm to help people with long-term ulnar nerve damage regain the ability to pinch. 17 adults aged 18-60 with stable joints and no other nerve injuries will be followed for 12 weeks after surgery. The goal is t…
Sponsor: Sohag University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could a stem cell transplant stop the immune system from attacking the brain?
Disease control OngoingThis phase 2 trial tests whether high-dose chemotherapy followed by a stem cell transplant can stop the immune system from attacking the nervous system in people with autoimmune neurologic diseases like multiple sclerosis and stiff person syndrome. The treatment aims to weaken th…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Vutrisiran shows promise for Long-Term control of rare heart condition
Disease control By invitation onlyThis study is for people with a rare heart condition called ATTR amyloidosis with cardiomyopathy, where abnormal protein builds up in the heart. It tests the long-term safety and effectiveness of a drug called vutrisiran, given as an injection every three months. About 700 adults…
Phase 3 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Milder stem cell transplant shows promise for kids with immune disorders
Disease control OngoingThis study tests a stem cell transplant using a milder chemotherapy-like regimen to treat children and young adults (up to age 28) with various immune system disorders. The goal is to help the donor stem cells settle in the body with fewer side effects. The study involves 20 part…
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Could a lymphatic bypass surgery soothe diabetic nerve damage?
Disease control By invitation onlyThis study tests a surgery called lymphovenous bypass for people with diabetic peripheral neuropathy, a common complication causing pain, numbness, and foot ulcers. The procedure aims to drain excess lymph fluid, which may reduce inflammation and nerve damage. Researchers will me…
Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could mild low-oxygen air boost nerve repair without surgery?
Disease control By invitation onlyThis study tests whether breathing short bursts of air with slightly less oxygen can help nerves in the hand heal better after injury. The therapy is non-invasive and aims to improve hand function and reduce pain. About 80 adults with severe carpal tunnel syndrome will be enrolle…
Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Nerve graft registry tracks recovery in thousands of patients
Disease control OngoingThis study follows over 3,000 people who received the Avance Nerve Graft to repair damaged peripheral nerves. Researchers are tracking safety, sensory and motor function recovery, and quality of life in real-world settings. The goal is to understand how well this processed human …
Sponsor: Axogen Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Hope for rare heart disease: new drug aims to slow deadly protein clumps
Disease control OngoingThis study tests a drug called vutrisiran in 655 adults with a rare heart condition caused by abnormal protein buildup (ATTR amyloidosis with cardiomyopathy). The drug is given as a shot every 3 months and aims to reduce deaths and heart-related hospital stays. The goal is to see…
Phase 3 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New stem cell approach aims to tame rare genetic diseases
Disease control OngoingThis study tests a stem cell transplant method for people with inherited metabolic disorders and severe osteopetrosis. The goal is to get the donor cells to take hold while keeping side effects low. Participants receive chemotherapy drugs before the transplant to prepare their bo…
Phase 2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New pill takes on Hard-to-Treat cancers in first human trial
Disease control OngoingThis early-stage trial tests an experimental oral drug called PRJ1-3024 in 39 adults with advanced solid tumors that have not responded to standard treatments. The main goal is to check safety and find the right dose. Researchers will also look for early signs that the drug may s…
Phase 1 • Sponsor: Zhuhai Yufan Biotechnologies Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New combo therapy targets nerve pain in rare blood cancers
Disease control OngoingThis study tests whether combining acalabrutinib with rituximab is safe and effective for people with nerve damage (neuropathy) linked to two blood conditions: IgM MGUS or Waldenstrom macroglobulinemia. The main goal is to see if the treatment lowers a key protein (IgM) in the bl…
Phase 2 • Sponsor: Shayna Sarosiek, MD • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Could a porcine nerve wrap save shoulder function after cancer surgery?
Disease control PausedThis study tests whether wrapping the spinal accessory nerve with a porcine (pig) tissue product during neck dissection for head and neck cancer can prevent shoulder problems. About 74 adults who have not had prior neck surgery will be enrolled. Researchers will measure shoulder …
Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New drug shows promise for Long-Term control of rare nerve disease
Disease control OngoingThis study looks at the long-term safety and effects of a drug called eplontersen in people with a rare inherited nerve disease called hATTR-PN. About 151 participants who completed earlier studies will receive regular injections of eplontersen. The goal is to see if the drug rem…
Phase 3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
SPINRAZA study tracks movement in adults with spinal muscular atrophy
Disease control OngoingThis study follows 20 adults with spinal muscular atrophy (SMA) type II who are already taking SPINRAZA. Researchers will measure motor function using a 32-point scale over 27 months to see if the drug helps maintain or improve movement. The goal is to better understand how SPINR…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Gene therapy aimed at cutting opioid use for diabetic nerve pain – but trial never started
Disease control CancelledThis study planned to test a gene therapy called VM202 in people with painful diabetic neuropathy who were already taking opioid painkillers. The goal was to see if VM202 could help them safely reduce their opioid dose. However, the trial was withdrawn before any participants wer…
Phase 2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Gene therapy boost for krabbe patients after transplant
Disease control OngoingThis early-phase trial tests a single infusion of a gene therapy called FBX-101 in 9 people with Krabbe disease who have already received a stem cell transplant. The therapy uses a harmless virus to deliver a working copy of the GALC gene, aiming to improve motor function and saf…
Phase 1/2 • Sponsor: Forge Biologics, Inc • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Gene therapy hope for babies with fatal muscle disease
Disease control OngoingThis study tests a new gene therapy called SKG0201 in 12 infants with spinal muscular atrophy type 1, a severe muscle-weakening disease. The treatment aims to improve survival and motor skills by delivering a working gene. Researchers are checking safety and how well the therapy …
Sponsor: Kun Sun • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
MS patients switch meds: will a cheaper option work just as well?
Disease control OngoingThis study looks at people with relapsing-remitting multiple sclerosis who switched from the drug MabThera to a similar, lower-cost medicine called Rixathon. Researchers want to see if the switch changes signs of nerve damage, new brain lesions, relapses, or disability. They will…
Sponsor: Uppsala University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
One-Person trial aims to treat rare nerve disorder with custom drug
Disease control By invitation onlyThis study tests a custom-made drug called an antisense oligonucleotide (ASO) designed for one person with Charcot-Marie-Tooth disease type 2D (CMT2D) caused by a specific GARS1 gene mutation. The drug aims to improve motor skills and quality of life. Only one participant is enro…
Phase 1/2 • Sponsor: n-Lorem Foundation • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Gene therapy for rare brain diseases: 5-Year safety check begins
Disease control OngoingThis study follows 7 people who previously received a gene therapy called AXO-AAV-GM2 for Tay-Sachs or Sandhoff disease — rare, fatal genetic disorders that destroy nerve cells. Researchers will track them for up to 5 years to see if the treatment remains safe and whether it help…
Sponsor: Terence Flotte • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Promising nerve pain drug trial for MGUS patients withdrawn before start
Disease control CancelledThis study aimed to test if daratumumab could improve nerve damage (peripheral neuropathy) in people with a blood condition called MGUS. Participants would have received weekly injections for two months, then biweekly for four more months. However, the trial was withdrawn before …
Phase 2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
One-Time gene injection aims to halt rare childhood paralysis
Disease control By invitation onlyThis early-stage trial tests a single injection of gene therapy for people with SMARD1 or CMT2S, rare diseases caused by mutations in the IGHMBP2 gene. The therapy delivers a working copy of the gene directly into the spinal fluid. Ten participants, ranging from infants to childr…
Phase 1/2 • Sponsor: Megan Waldrop • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
One Patient's last hope: stem cells for rare nerve disease
Disease control Expanded access (ended)This study gives one patient with CIDP access to their own stored stem cells to see if it's safe and might help. The patient receives multiple infusions over 44 weeks and is followed for a year. Because it's only one person, the results are very limited.
Sponsor: Hope Biosciences Research Foundation • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New drug targets genetic weakness in Hard-to-Treat cancers
Disease control OngoingThis study tests a drug called pacritinib in people with advanced solid tumors (like breast cancer) that have a specific genetic change called 1q21.3 amplification. The goal is to see if the drug can shrink tumors or slow their growth. About 74 adults whose cancer has not respond…
Phase 1/2 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New combo shows promise for tough kidney cancers
Disease control OngoingThis study tests two drugs, nivolumab and cabozantinib, together in 60 people with advanced or metastatic non-clear cell kidney cancer. The goal is to see how well the combination shrinks tumors. Participants take cabozantinib daily and receive nivolumab infusions every two weeks…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can a cancer drug help CIDP patients ditch their meds?
Disease control CancelledThis study planned to test the drug rituximab in people with chronic inflammatory demyelinating polyneuropathy (CIDP), a nerve condition that causes weakness and numbness. The goal was to see if rituximab could help certain patients stop their current treatments and achieve long-…
Phase 2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 26, 2026 18:31 UTC
-
Gene therapy hope for rare brain disease in children
Disease control OngoingThis study tests a single infusion of OTL-200 gene therapy in 6 people with late juvenile metachromatic leukodystrophy (MLD), a rare genetic disease that damages the brain and nerves. The therapy uses the patient's own blood stem cells, modified to produce a missing enzyme. Resea…
Phase 3 • Sponsor: Orchard Therapeutics • Aim: Disease control
Last updated Jun 26, 2026 13:33 UTC
-
New training program aims to catch rare heart disease earlier
Diagnosis OngoingThis study enrolls about 4,000 adults aged 60 and older with heart failure who are at high risk for ATTR amyloidosis, a rare disease that stiffens the heart. Doctors receive special training on how to spot and diagnose the condition using standard tests. The goal is to see if thi…
Sponsor: AstraZeneca • Aim: Diagnosis
Last updated Aug 09, 2026 00:00 UTC
-
New york program offers extra screening for 100,000 newborns
Diagnosis By invitation onlyScreenPlus is a large pilot program that offers families the option to have their newborn screened for a panel of rare genetic disorders, in addition to standard newborn screening. The study aims to screen 100,000 infants born at eight hospitals in New York. Researchers will eval…
Sponsor: Albert Einstein College of Medicine • Aim: Diagnosis
Last updated Jul 30, 2026 00:00 UTC
-
Could a common hand condition reveal hidden heart disease? new imaging trial investigates
Diagnosis By invitation onlyThis study tests whether a radioactive tracer called 124I-evuzamitide can detect amyloid deposits in the heart and elsewhere in people aged 60 and older who have lumbar spinal stenosis or carpal tunnel syndrome. Participants will receive a single dose of the tracer and undergo a …
Phase 2 • Sponsor: University of Tennessee Graduate School of Medicine • Aim: Diagnosis
Last updated Jul 23, 2026 00:00 UTC
-
Could a tiny jolt to the head diagnose balance problems?
Diagnosis By invitation onlyThis early study will test whether weak electrical currents applied to the head can help diagnose balance disorders like vestibular schwannoma and vestibular neuritis. Researchers will measure how 30 people with these conditions sway or move in response to the stimulation. The go…
Sponsor: Aalto University • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Newborn screening study aims to catch rare diseases at birth
Diagnosis OngoingThis study offers voluntary screening for newborns in North Carolina to detect a wide range of rare health conditions early. Using a small blood sample already collected at birth, the program tests for dozens of disorders, including spinal muscular atrophy, cystic fibrosis, and m…
Sponsor: RTI International • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Needle-Free carpal tunnel diagnosis on the horizon?
Diagnosis By invitation onlyThis study explores whether ultrasound elastography, a non-invasive imaging technique, can accurately diagnose carpal tunnel syndrome (CTS) without the need for painful needle-based nerve tests. Researchers will enroll 80 participants—some with CTS and some healthy volunteers—to …
Sponsor: Da Nang Family General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 11:04 UTC
-
Brain scan breakthrough could save babies from rare disease
Diagnosis OngoingThis study looks at whether a special brain scan called diffusion tensor imaging (DTI) can help doctors find Krabbe disease in newborns and decide who needs urgent treatment. About 100 babies with a positive newborn screen or family history of Krabbe disease will be scanned and f…
Sponsor: University of Pittsburgh • Aim: Diagnosis
Last updated Jun 27, 2026 09:11 UTC
-
Simple blood test could catch hidden heart disease in seniors
Diagnosis By invitation onlyThis study is testing a way to find cardiac amyloidosis—a rare but serious heart condition—earlier in people aged 65 and older. Researchers in Turkey will screen 800 patients at family medicine clinics using simple blood tests and medical history. The goal is to see if this appro…
Sponsor: Kotyora Family Medicine Health Management and Education Association • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
Algorithm aims to spot rare heart disease in medical records
Diagnosis CancelledThis study aimed to test a computer algorithm that uses insurance claims data to identify people with ATTR amyloidosis, a rare disease that affects the heart and nerves. Researchers planned to check how well the algorithm worked by reviewing medical records. However, the study wa…
Early phase 1 • Sponsor: Yale University • Aim: Diagnosis
Last updated Jun 26, 2026 18:38 UTC
-
New test could predict falls in muscle disease patients
Diagnosis By invitation onlyThis study aims to create a simple test battery to determine fall risk in people with neuromuscular disorders, such as muscular dystrophy or ALS. Researchers will assess 108 participants using several physical tests like walking, standing, and rising from a chair. The goal is to …
Sponsor: LMU Klinikum • Aim: Diagnosis
Last updated Jun 26, 2026 16:30 UTC
-
New screening tool aims to catch diabetic nerve damage early
Diagnosis OngoingThis study tests a short questionnaire called ACT to see if it can accurately detect nerve damage in the feet and legs of people with diabetes. Researchers will compare it to standard screening tools and an eye test that looks at tiny nerve fibers. The goal is to find a simple, n…
Sponsor: Weill Cornell Medical College in Qatar • Aim: Diagnosis
Last updated Jun 26, 2026 14:24 UTC
-
New hope: natural compound may stop chemo nerve pain
Prevention OngoingThis study tests a natural substance called GM1 to see if it can prevent nerve damage (pain, numbness, tingling) caused by the chemotherapy drug paclitaxel in people with metastatic breast cancer. About 98 participants will receive either GM1 or a placebo alongside their chemo. T…
Phase 2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Wearable insoles warn of foot pressure to stop diabetic ulcers
Prevention OngoingThis trial tests a wearable insole system that monitors foot pressure, temperature, and movement, giving real-time alerts to help users shift weight and avoid injury. The study includes people with type 1 or 2 diabetes who have nerve damage and a recent history of healed foot ulc…
Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Jul 16, 2026 00:00 UTC
-
New pill aims to stop chemo from stealing hearing
Prevention CancelledThis study was designed to test whether an oral drug called SPI-1005 could prevent hearing loss and ringing in the ears caused by platinum-based chemotherapy. It was planned for adults with advanced lung or head and neck cancer. The study was withdrawn before enrolling any partic…
Phase 2 • Sponsor: Sound Pharmaceuticals, Incorporated • Aim: Prevention
Last updated Jun 27, 2026 13:01 UTC
-
Can a common drug stop Chemo's nerve pain?
Prevention PausedThis phase II trial tests whether riluzole, a drug used for ALS, can prevent nerve damage caused by oxaliplatin chemotherapy in people with stage II/III colorectal cancer. About 80 participants will receive either riluzole or a placebo during their chemo. The study is currently s…
Phase 2 • Sponsor: UNICANCER • Aim: Prevention
Last updated Jun 27, 2026 12:35 UTC
-
Cold hands, healthy nerves? study tests cryotherapy to block chemo side effect
Prevention PausedThis study tests whether wearing cold gloves during chemotherapy can prevent peripheral neuropathy (nerve damage causing numbness, tingling, or pain) in colon cancer patients. Forty adults with stage III colon cancer who are about to start a common chemo regimen (CAPOX) will be r…
Sponsor: NYU Langone Health • Aim: Prevention
Last updated Jun 27, 2026 09:10 UTC
-
Simple glove trick may shield breast cancer patients from chemo nerve pain
Prevention OngoingThis study tests whether wearing two layers of surgical gloves during paclitaxel chemotherapy can prevent nerve damage in the hands. About 104 breast cancer patients will be randomly assigned to wear the gloves or not. Researchers will compare changes in nerve pain and function b…
Sponsor: Young-Joon Kang • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
Common antidepressant may shield cancer patients from chemo nerve damage
Prevention OngoingThis phase II/III trial tests whether duloxetine, a drug used for depression and pain, can prevent the nerve damage (pain, tingling, numbness) caused by oxaliplatin chemotherapy in stage II-III colorectal cancer patients. About 220 participants will receive either duloxetine or a…
Phase 2/3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Prevention
Last updated Jun 27, 2026 08:14 UTC
-
Cookie cure? golden rice snack may prevent diabetic nerve damage
Prevention OngoingThis study tests whether cookies made from golden rice and red betel leaf can help prevent diabetic neuropathy, a common nerve damage complication of diabetes. 102 adults with diabetes will eat one cookie daily for 28 days. Researchers will measure changes in nerve symptoms and b…
Sponsor: Hasanuddin University • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC
-
Elastic band exercises may stop diabetic foot ulcers before they start
Prevention OngoingThis study looks at whether foot and ankle exercises using elastic bands can help prevent diabetic foot ulcers in people with diabetic neuropathy. About 80 participants with type 2 diabetes and nerve damage in their feet will do these exercises. Researchers will track how many ul…
Sponsor: St Elisabeth School Health Science • Aim: Prevention
Last updated Jun 27, 2026 07:58 UTC
-
Massage may ease chemo nerve damage
Symptom relief OngoingThis study looks at whether massage therapy can reduce nerve problems like pain, numbness, and tingling caused by chemotherapy in people with breast or digestive system cancers. About 90 participants will receive massage sessions to see if it improves symptoms and quality of life…
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a robotic exoskeleton rebuild arm strength after Guillain-Barré?
Symptom relief OngoingGuillain-Barré syndrome can leave people with weak arms and hands, making daily tasks hard. This trial tests whether adding robot-assisted arm training to usual therapy helps adults in the sub-acute phase of recovery. Participants use the Armeo Power 2 exoskeleton for 20 sessions…
Phase 4 • Sponsor: I.R.C.C.S. Fondazione Santa Lucia • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a single nerve injection quiet chronic pelvic pain?
Symptom relief OngoingResearchers are testing whether an ultrasound-guided injection of the local anesthetic articaine plus the steroid triamcinolone near the pudendal nerve reduces pain in adults with pudendal neuralgia, a chronic perineal pain condition. The trial enrolls 120 people whose pain has l…
Sponsor: Irkutsk State Medical University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
New shot aims to quiet chemo nerve pain
Symptom relief OngoingThis study tests an injected drug called Halneuron to see if it can safely reduce nerve pain caused by chemotherapy. About 240 adults who have nerve pain from platinum or taxane chemo will receive either Halneuron or a placebo shot. The goal is to measure pain relief, sleep, fati…
Phase 2 • Sponsor: Dogwood Therapeutics Inc. • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Massage gun vs. hands: which eases Post-Hip-Surgery numbness?
Symptom relief By invitation onlyAfter hip replacement through a front incision, many people feel numbness, tingling, or burning in the thigh because a nearby nerve gets irritated. This trial tests whether a handheld massage gun, used at home twice a day for six weeks, can ease those symptoms faster than gentle …
Sponsor: Zachary M Ricciardelli • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Elbow nerve surgery showdown: which procedure works best?
Symptom relief OngoingThis study compares two common surgeries for ulnar neuropathy at the elbow: simple decompression and subcutaneous anterior transposition. Researchers will enroll 378 adults with confirmed ulnar nerve issues to see which surgery better improves hand function and reduces pain. Part…
Sponsor: University of Michigan • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
New pill could ease diabetic nerve pain for good
Symptom relief OngoingThis study tests a drug called suzetrigine (VX-548) for long-term safety and pain relief in people with diabetic peripheral neuropathy. About 455 adults who completed a prior 12-week study will take the drug for up to one year. Researchers will track side effects and changes in p…
Phase 3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Can freezing a nerve silence the 'Suicide Disease'?
Symptom relief OngoingThis trial tests whether a freezing technique called cryoneurolysis can reduce the intense facial pain of trigeminal neuralgia, a condition often described as one of the most painful known. Adults with the condition will be randomly assigned to receive either the real freezing tr…
Sponsor: St. Olavs Hospital • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
Can adding shockwaves boost bowen therapy for buttock pain?
Symptom relief By invitation onlyThis trial tests whether adding extracorporeal shockwave therapy (ESWT) to the Bowen Technique, a gentle manual therapy, improves outcomes for people with deep gluteal pain syndrome. Forty-six adults aged 25 to 45 with buttock pain will be randomly assigned to receive either Bowe…
Sponsor: University of Management and Technology Sialkot Pakistan • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Vitamin B3 derivative may soothe Chemotherapy's lingering nerve damage
Symptom relief OngoingThis phase 2 trial tests whether nicotinamide riboside (NIAGEN), a form of vitamin B3, can reduce persistent nerve pain and numbness in cancer survivors who completed chemotherapy with taxane or platinum drugs 1 to 12 months earlier. Participants take either NIAGEN or a placebo d…
Phase 2 • Sponsor: Donna Hammond, PhD • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Video analysis could personalize rehab for chemo nerve damage
Symptom relief By invitation onlyThis study tests whether a personalized exercise program, guided by video-based movement analysis, can help people with chemotherapy-induced peripheral neuropathy (CIPN) — a common side effect causing numbness, tingling, and balance problems. The trial enrolls adults with breast,…
Sponsor: Seoul National University Bundang Hospital • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Could a blood flow 'Tourniquet' workout repair diabetic nerve damage?
Symptom relief OngoingThis trial tests whether blood flow restriction (BFR) training—exercising with a cuff that partially limits blood flow—can improve blood sugar control, nerve function, pain, and quality of life in people with type 2 diabetes and peripheral neuropathy. Participants will be randoml…
Sponsor: Superior University • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Massage showdown: which therapy eases piriformis pain best?
Symptom relief By invitation onlyThis study compares two types of hands-on therapy—Stecco Fascial Manipulation and Rolfing Structural Integration—for people with piriformis syndrome, a condition that causes buttock and leg pain. Forty-two adults aged 25 to 45 with at least four weeks of pain will receive four we…
Sponsor: Danyal Ahmad • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Brain training offers new hope for chemo nerve pain
Symptom relief OngoingThis study tests whether a non-invasive therapy called neurofeedback can help people with chemotherapy-induced nerve pain learn to change their own brain waves to feel less pain. About 80 participants will be assigned to either receive neurofeedback training or a control conditio…
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Needles vs. nerve pain: can acupuncture shield breast cancer patients from chemotherapy side effects?
Symptom relief OngoingThis trial tests whether acupuncture can prevent taxane-induced peripheral neuropathy (TIPN) — nerve damage causing pain and tingling in arms and legs — from worsening in breast cancer patients receiving weekly taxane chemotherapy. Participants with early-stage breast cancer who …
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Can a single ketamine infusion rewrite the story of fibromyalgia pain?
Symptom relief By invitation onlyThis trial tests whether slow intravenous ketamine infusions can safely reduce pain in people with fibromyalgia. Researchers will measure pain levels before and after treatment, and track how long any relief lasts. They will also look for traits that predict who responds best, ai…
Sponsor: Wilderman Medical Clinic • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Pepper-Based patch tested against Kids' chronic nerve pain
Symptom relief OngoingThis study follows children aged 0 to 18 with chronic localized neuropathic pain who receive an 8% capsaicin patch as part of their routine care. Researchers will track whether the patch reduces pain and lessens the need for other pain treatments over six months. The goal is to s…
Sponsor: University Hospital, Brest • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Could a tiny nerve zap restore erectile function?
Symptom relief OngoingThis study tests whether low-dose electrical stimulation of the pudendal nerve can improve erectile function in men with mild to moderate erectile dysfunction. Twenty-four men will receive a 20-minute stimulation session, and researchers will measure changes in erection hardness,…
Sponsor: Camilo Jose Cela University • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Could a simple nerve zap treat erectile dysfunction?
Symptom relief OngoingThis study tests whether stimulating the pudendal nerve with a small electrical current can improve erections in men with erectile dysfunction. 72 men aged 18-60 will receive either real stimulation or a sham procedure. Researchers will measure changes in erectile function, hardn…
Sponsor: Camilo Jose Cela University • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Acupuncture needles take on chemo nerve pain in major trial
Symptom relief OngoingThis study tests if acupuncture can reduce nerve pain caused by chemotherapy in cancer survivors. About 255 people who finished chemo at least three months ago will receive either real or sham acupuncture. The goal is to see if this drug-free approach can ease pain and improve da…
Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Sound waves zapping pain: new hope for facial neuralgia?
Symptom relief OngoingThis early-phase study tests whether MRI-guided focused ultrasound can safely reduce severe facial pain in people with trigeminal neuralgia that hasn't responded to medication. Ten adults aged 21-75 with chronic pain for over 6 months will receive a precise ultrasound treatment t…
Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Can a capsaicin patch ease diabetic foot pain? new study investigates
Symptom relief OngoingThis study is testing whether repeated use of QUTENZA (a capsaicin 8% patch) can reduce pain and the need for painkillers in adults with painful diabetic nerve damage in the feet. About 144 participants will receive up to three patch applications, each 12 weeks apart. Researchers…
Sponsor: Averitas Pharma, Inc. • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Ancient herb moutan cortex may soothe chemo nerve damage
Symptom relief CancelledThis study tests whether Moutan Cortex, a Chinese herb containing paeonol, can relieve nerve pain and numbness caused by chemotherapy in breast cancer patients. Participants take the herb or a placebo daily for four weeks. Researchers measure pain levels and nerve function to see…
Sponsor: Taiwan Municipal An-Nan Hospital-China Medical University • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Menthol gloves may soothe nerve pain caused by chemotherapy
Symptom relief OngoingThis study tests whether menthol-infused gloves and foot-covers can relieve numbness, pain, and unusual sensations caused by chemotherapy. Cancer patients who have completed or received at least two cycles of certain chemo drugs will wear the gloves or a sham version for five min…
Phase 2 • Sponsor: Taiwan Municipal An-Nan Hospital-China Medical University • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Ultrasound-Guided injections may offer superior pain relief for common arm conditions
Symptom relief OngoingThis study compares three treatments for shoulder impingement and carpal tunnel syndrome: ultrasound-guided corticosteroid injections, standard injections guided by touch, and oral pain medication. Researchers want to see which approach provides the best long-term pain relief, im…
Phase 4 • Sponsor: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Scrambler therapy offers hope for young cancer survivors with nerve pain
Symptom relief OngoingThis study looks at whether Scrambler therapy can safely reduce painful nerve damage caused by chemotherapy in adolescents and young adults (ages 15-39) who have finished active cancer treatment. Participants are randomly assigned to receive the therapy right away or after a wait…
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Freezing nerves could offer new hope for diabetic foot pain
Symptom relief OngoingThis study tests a procedure called cryoneurolysis, which uses a small probe to freeze nerves in the foot and block pain signals. It is for adults with painful diabetic neuropathy who have at least moderate pain daily. Thirty participants will be randomly assigned to receive eith…
Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Tiny implant zaps nerve pain: new study tests relief without drugs
Symptom relief OngoingThis study tests a small implanted device that sends mild electrical pulses to nerves to relieve chronic pain from injury or surgery. About 89 adults with long-lasting pain in the back, shoulder, knee, or foot will either get the implant plus usual care or usual care alone. The g…
Sponsor: Nalu Medical, Inc. • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Shocking nerve pain away: new device trial for diabetic neuropathy
Symptom relief OngoingThis study tests whether a device that sends mild electrical pulses to the spinal cord (10 kHz SCS) can reduce pain and improve nerve function in people with painful diabetic neuropathy. About 143 participants will either get standard medical care alone or the device plus standar…
Sponsor: Nevro Corp • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Zapping the brain to quiet diabetic nerve pain
Symptom relief OngoingThis study tests whether two non-invasive brain stimulation techniques—transcranial Direct Current Stimulation (tDCS) and Transcranial Ultrasound (TUS)—can reduce chronic pain in people with diabetic neuropathy. Participants, aged 40 to 80 with foot pain lasting at least 6 months…
Sponsor: Case Western Reserve University • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Spinal implant offers new hope for diabetic leg pain
Symptom relief OngoingThis study looks at how well a spinal cord stimulator works in real-world settings for people with long-term leg pain caused by diabetic neuropathy. About 500 participants will receive the implant and be followed for a year. Researchers will measure pain relief, quality of life, …
Sponsor: Nevro Corp • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Brain training plus drug may ease chemo nerve damage
Symptom relief OngoingThis phase 2 trial tests whether combining neurofeedback (a brain-wave training therapy) with the drug duloxetine can better relieve nerve pain caused by chemotherapy than either treatment alone. About 336 cancer survivors with persistent nerve pain will be randomly assigned to o…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Laser light may soothe diabetic nerve pain
Symptom relief OngoingThis study tests a non-invasive light therapy called photobiomodulation (low-level laser) for people with diabetic peripheral neuropathy—nerve damage causing pain, tingling, and numbness in the feet. 36 adults with type 2 diabetes and foot pain for at least 6 months will receive …
Sponsor: University of Faisalabad • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
New device combo aims to quiet jaw pain without drugs
Symptom relief OngoingThis study tests whether two devices, used one after the other, can reduce pain and disability from temporomandibular joint (TMJ) disorders. Adults aged 22 and older with TMJ pain will receive four treatment sessions and be followed for three months. Researchers will measure chan…
Sponsor: BTL Industries Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Laser light shows promise for rare nerve pain
Symptom relief By invitation onlyThis study tests whether photobiomodulation (low-level laser therapy) can reduce pain and disability in people with anti-MAG neuropathy, a rare nerve condition. Ten participants will receive 16 laser sessions over six weeks. Researchers will measure changes in disability, pain, a…
Sponsor: Centre Hospitalier de Cornouaille • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Custom 3D printed insoles may help diabetic patients avoid foot ulcers
Symptom relief OngoingThis study tests whether 3D printed custom insoles are better than regular ready-to-wear insoles at reducing foot pressure in people with diabetic neuropathy. High foot pressure can lead to ulcers and mobility problems. Twenty-two adults with diabetes and nerve damage will be ran…
Sponsor: University of Faisalabad • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Vibrating leg device tested to improve walking in young cancer survivors
Symptom relief OngoingThis pilot study tests whether a vibrating device strapped to the leg can improve walking in young cancer survivors (ages 6-39) who have nerve damage from chemotherapy. Ten participants will have the device applied to leg muscles while their step times are measured. The goal is t…
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:08 UTC
-
Ultrasound-Delivered pain gel shows promise for carpal tunnel sufferers
Symptom relief OngoingThis study tests whether a pain-relief gel (pregabalin) delivered through the skin using ultrasound can reduce pain and improve hand function in people with carpal tunnel syndrome. The treatment is given four times a week for a month, and compared to standard ultrasound therapy w…
Sponsor: University of Faisalabad • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Could botox stop nerve pain before it becomes chronic?
Symptom relief CancelledThis study tests whether giving Botox injections early can reduce nerve pain that occurs after chest surgery (thoracoscopy or thoracotomy). Participants have had daily nerve pain for three months. The trial compares Botox to a placebo to see if it lowers pain intensity and preven…
Phase 3 • Sponsor: University Hospital, Limoges • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Exercise program aims to ease chemo nerve damage in cancer survivors
Symptom relief OngoingThis study tests whether a 10-week, at-home exercise program is safe and helpful for cancer survivors who have ongoing nerve pain, numbness, or tingling from chemotherapy. About 40 participants will do remote exercise sessions and health coaching calls. The goal is to see if the …
Phase 1 • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Nerve cap aims to ease pain after limb loss
Symptom relief OngoingThis study tests a special nerve cap (Axoguard Large-Diameter Nerve Cap) in 15 adults who have had a limb injury or amputation. The cap is placed over the cut nerve end to protect it and may help reduce chronic nerve pain. The goal is to see if the cap is safe and works well befo…
Sponsor: Axogen Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New hope for chemo pain: nerve zap study launches
Symptom relief OngoingThis study tests a treatment called neuromodulation to see if it can reduce nerve pain caused by chemotherapy. About 24 adults with nerve pain in their legs from certain chemo drugs will take part. Researchers will check for side effects and measure changes in pain and nerve func…
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Spinal zap trial aims to calm chemo nerve pain
Symptom relief PausedThis small pilot study tests whether a closed loop spinal cord stimulator can reduce pain and improve quality of life for people with nerve damage from chemotherapy. Ten adults with chemotherapy-induced peripheral neuropathy in their legs will receive the device and be monitored …
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New hope for back pain sufferers: no surgery needed?
Symptom relief OngoingThis study looks at whether a non-surgical treatment called spinal decompression can help people with chronic low back pain. About 42 adults with back pain from disc problems or sciatica will receive the treatment over 12 weeks. Researchers will use MRI scans and movement tests t…
Sponsor: University of South Florida • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Could a daily 5-Minute mask soothe nerve pain?
Symptom relief OngoingThis phase 2 trial tests a special hand and foot mask designed to ease nerve pain caused by chemotherapy or diabetes. Sixty adults will apply the mask daily for 5 minutes over one week. Researchers will measure changes in symptoms and quality of life using questionnaires.
Phase 2 • Sponsor: SHIANG-SUO HUANG • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Vitamin d may ease Chemo's nerve pain
Symptom relief PausedThis study looks at whether taking vitamin D can reduce nerve pain caused by chemotherapy in people with low vitamin D levels. About 120 cancer patients will be split into two groups: one gets vitamin D supplements, the other gets standard care. The goal is to see if vitamin D he…
Phase 2 • Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
New device aims to zap diabetic nerve pain
Symptom relief By invitation onlyThis study tests a spinal cord stimulator (BurstDR) to relieve chronic pain from diabetic neuropathy. Twenty adults with long-lasting leg pain will try a temporary device for one week. If their pain drops by at least half, they can get a permanent implant. The study tracks pain l…
Sponsor: TriCity Research Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Robot walks could ease nerve pain in spinal injury patients
Symptom relief OngoingThis study tests whether walking with a robotic exoskeleton three times a week for 12 weeks can reduce nerve pain in people with spinal cord injury. Forty adults with traumatic spinal injury and persistent nerve pain will be randomly assigned to either robotic walking or a relaxa…
Sponsor: University College Dublin • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New nerve patch could ease pain after biopsy
Symptom relief OngoingThis study tests a biodegradable tube that is placed over a cut nerve during a leg biopsy. The goal is to see if it is safe and reduces common side effects like pain, redness, and swelling. Twenty adults with various nerve conditions are taking part, and half will get the tube wh…
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Can squeezing hands and feet stop chemo nerve pain?
Symptom relief OngoingThis study tests whether wearing pressurized gloves and foot caps during chemotherapy can prevent nerve damage (peripheral neuropathy) caused by the drug paclitaxel. It involves 182 people with nasopharyngeal cancer who have not yet started treatment. Each patient serves as their…
Sponsor: Sun Yat-sen University • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
Scientists pinpoint ideal painkiller dose for diabetic foot operations
Symptom relief OngoingThis study aims to find the smallest effective dose of the numbing drug ropivacaine for blocking leg nerves during diabetic foot surgery. Researchers will test different concentrations in 45 adults to see which dose works best for 90% of patients. The goal is to provide effective…
Sponsor: Seoul National University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
Ketamine infusion may ease chronic nerve pain in brachial plexus injuries
Symptom relief By invitation onlyThis study tests whether giving ketamine during and after surgery can reduce chronic nerve pain in people with traumatic brachial plexus injuries. About 100 adults will receive a ketamine infusion during their reconstructive surgery and for 24 hours afterward. Researchers will me…
Phase 4 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Exercise may soothe chemo nerve pain, trial hopes
Symptom relief OngoingThis study tests whether a structured exercise program can reduce chemotherapy-induced peripheral neuropathy (CIPN) — nerve damage causing pain, numbness, or tingling. About 133 cancer patients who received certain chemotherapies will either follow an exercise plan or receive sta…
Sponsor: University of Rochester NCORP Research Base • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Could a Hands-On therapy help diabetic nerve pain and blood sugar?
Symptom relief OngoingThis pilot study tested whether two types of manual therapy (nerve mobilization and neck-based techniques) could help control blood sugar and reduce pain in 75 adults with diabetic peripheral neuropathy. Participants received twice-weekly sessions for 12 weeks, and the study focu…
Sponsor: Abeer Abdrabo • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Can a simple muscle zap boost pain relief for back pain sufferers?
Symptom relief By invitation onlyThis study looks at whether adding a daily 30-minute muscle stimulation session can improve pain control and quality of life for people who already have a spinal cord stimulator (BurstDR) for chronic back pain. Sixty adults with failed back surgery syndrome or persistent spinal p…
Sponsor: Jessa Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
Can learning about pain or using tape ease carpal tunnel symptoms?
Symptom relief OngoingThis study tests two simple treatments for mild to moderate carpal tunnel syndrome: pain neuroscience education (learning how the brain processes pain) and kinesio taping (applying elastic tape to the wrist). Sixty adults aged 18 to 60 with symptoms for at least 3 months will rec…
Sponsor: Middle East University • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
Can remote rehab beat home workouts for piriformis pain?
Symptom relief By invitation onlyThis study compares two exercise programs—asynchronous telerehabilitation (remote guidance) and a standard home exercise plan—for people with piriformis syndrome, a condition causing buttock and leg pain. About 46 adults aged 18-45 with confirmed diagnosis will participate. The g…
Sponsor: Hacettepe University • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Sugar water injection may ease carpal tunnel pain
Symptom relief OngoingThis study tests whether injecting a 5% dextrose (sugar water) solution around the nerve in the wrist can reduce pain and improve hand function in people with mild to moderate carpal tunnel syndrome. About 96 adults who haven't gotten better with standard care will receive the in…
Sponsor: Antalya Training and Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
New dissolving film may stop dangerous episodes in rare nerve disease
Symptom relief By invitation onlyThis study tests a medicated film placed under the tongue to quickly ease severe episodes (autonomic crises) in people with familial dysautonomia. The film contains dexmedetomidine, a drug that calms the body's stress response. Researchers will check if it reduces symptoms like h…
Phase 2 • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
New online program aims to ease chronic facial pain without drugs
Symptom relief OngoingThis study tests a self-guided web program called Face-Forward-Web for adults with chronic orofacial pain (lasting over 3 months). The program includes five 30-minute video sessions teaching relaxation, mindfulness, and coping skills. Researchers will enroll up to 30 participants…
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
New hope for rare burning pain: drug trial targets genetic cause
Symptom relief By invitation onlyThis early-stage study tests whether BHV-7000 can reduce chronic pain in people with inherited erythromelalgia, a rare condition causing severe burning pain due to a genetic mutation. Only 5 adults with a specific NaV1.7 mutation will participate, comparing the drug to a placebo …
Phase 1 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Could a common constipation drug help diabetics?
Symptom relief OngoingThis study tests whether linaclotide (Linzess) can improve bowel movement frequency in people with type 2 diabetes who have chronic constipation. About 23 participants will receive either the drug or a placebo for two weeks, then switch after a break. The goal is to see if the dr…
Phase 4 • Sponsor: Texas Tech University Health Sciences Center, El Paso • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Could a simple tourniquet change cut Post-Surgery pain and opioid use?
Symptom relief OngoingThis study tests whether using a lower-pressure tourniquet during orthopedic surgeries can reduce pain and the need for opioid painkillers afterward. Standard tourniquets use high pressure, which can cause muscle weakness and pain. The experimental device sets pressure based on t…
Sponsor: The Methodist Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
New pain drug mirogabalin tested in Real-World diabetes study
Symptom relief OngoingThis study is tracking over 700 Chinese adults with diabetic peripheral neuropathic pain who are starting mirogabalin. Researchers are monitoring side effects and how well the drug works in everyday medical practice. The goal is to see if mirogabalin is a safe and effective optio…
Sponsor: Daiichi Sankyo • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Mud vs. wax: which soothes carpal tunnel pain best?
Symptom relief By invitation onlyThis study tests whether warm paraffin wax baths or mud therapy (peloidotherapy) can reduce pain and improve hand function in people with mild to moderate carpal tunnel syndrome. Ninety adults will be split into three groups: one gets mud plus home exercises, another gets wax plu…
Sponsor: Konya Beyhekim Training and Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Carpal tunnel showdown: shots or knife?
Symptom relief OngoingThis study looks at two treatment plans for carpal tunnel syndrome, which causes hand numbness and pain. One plan starts with up to two steroid injections, then offers surgery if needed. The other plan goes straight to surgery. About 258 adults with mild to moderate symptoms will…
Phase 4 • Sponsor: Diakonhjemmet Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Soundwave therapy shows promise for chemo nerve damage
Symptom relief OngoingThis study tests a device called SensoniQ® Treatment Station that uses low frequency soundwaves to prevent or reduce nerve pain caused by chemotherapy in people with gynecologic cancer. The trial includes 80 participants, some starting chemo and others with lasting nerve pain. Re…
Sponsor: Augusta University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Could a short steroid course after surgery reduce pain and nausea?
Symptom relief By invitation onlyThis study looks at whether a 6-day course of oral steroids after orthopedic surgery can help reduce pain, nausea, and improve movement. About 500 adults having common surgeries like joint replacement or fracture repair will be randomly assigned to receive either standard care or…
Phase 4 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Magnetic pulses to the brain may ease stubborn nerve pain
Symptom relief OngoingThis study tests whether repeated magnetic pulses (rTMS) aimed at the brain's motor area can safely reduce chronic nerve pain that hasn't responded to other treatments. About 32 adults with conditions like post-stroke pain, trigeminal neuralgia, or spinal cord injury will receive…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Micro-Implant zaps nerve pain: new hope for chronic sufferers?
Symptom relief OngoingThis study tests a small, implantable device that stimulates nerves to relieve chronic pain after injury or surgery. About 185 adults with peripheral neuralgia will either receive the stimulator plus standard medical care or standard care alone. The goal is to see if the device p…
Sponsor: Nalu Medical, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
Exercise may ease pain in lung cancer survivors, small study hopes
Symptom relief OngoingThis study tests whether a progressive exercise program can reduce chronic pain in veteran lung cancer survivors aged 60-80. Nine participants will do treadmill walking, resistance bands, and balance exercises. The goal is to see if exercise can be a safe alternative to opioids f…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Yoga vs. nerve pain: could stretching replace pills for chemo side effects?
Symptom relief OngoingThis study tests whether yoga can reduce nerve pain caused by chemotherapy in cancer survivors. About 227 participants will either take yoga classes twice a week for 8 weeks, attend educational sessions, or receive standard care. Researchers will measure pain, balance, fall risk,…
Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
New pill could ease the 'Suicide Disease' for patients failed by current meds
Symptom relief OngoingThis study tests a daily drug called basimglurant for adults with trigeminal neuralgia, a condition causing severe facial pain often called the 'suicide disease.' The trial includes 166 people who still have pain despite current treatments. After an 8-week run-in on the drug, par…
Phase 2/3 • Sponsor: Noema Pharma AG • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Could a 12-minute electrical zap ease your numb fingers?
Symptom relief OngoingThis study looks at whether a type of electrical current called diadynamic current can reduce pain and improve hand function in people with carpal tunnel syndrome. About 80 adults with mild to moderate carpal tunnel syndrome will receive this therapy along with standard care like…
Sponsor: Duzce University • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Could a gentle zap to the spine ease chronic nerve pain?
Symptom relief By invitation onlyThis study tests whether a noninvasive electrical stimulation device placed on the skin over the spine can reduce pain and improve quality of life in people with neuropathic (nerve) pain. About 62 adults with chronic low back pain from nerve damage will receive either real or sha…
Sponsor: Nanchang University Affiliated Rehabilitation Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Migraine drug could soothe stubborn facial pain
Symptom relief By invitation onlyThis small study tests whether eptinezumab, a drug used for migraines, can reduce pain in people with atypical facial pain that hasn't responded to other treatments. Ten participants will receive two intravenous infusions three months apart. The main goal is to see if the drug im…
Sponsor: Alenka Spindler-Vesel • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Can herbs and spinal manipulation ease chronic back pain? new study investigates
Symptom relief OngoingThis study looks at whether a combination of herbal medicine and Chuna manual therapy (a Korean spinal manipulation technique) can safely reduce pain and improve walking ability in people with low back pain or sciatica caused by lumbar spinal stenosis or spondylolisthesis. Resear…
Sponsor: Jaseng Medical Foundation • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Can ketamine ease chronic pain? new study seeks answers
Symptom relief By invitation onlyThis study looks at adults with chronic pain who receive ketamine infusions at Stanford's Pain Management Center. Researchers want to understand which patients improve and what factors predict a good response. The goal is to better tailor this treatment to individuals.
Sponsor: Theresa Lii • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
New pain relief for diabetic nerves? trial pulled before start
Symptom relief CancelledThis study was designed to test a new drug called N0750 against two standard pain medications (Cymbalta and Lyrica) for painful diabetic peripheral neuropathy. It planned to enroll adults with diabetes and nerve pain for at least 3 months. However, the trial was withdrawn before …
Phase 3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Simple stretches may ease piriformis pain: new study
Symptom relief OngoingThis study looks at whether adding dynamic stretching to foam rolling helps people with piriformis syndrome more than foam rolling alone. Forty adults aged 35–50 with buttock pain will do either foam rolling or foam rolling plus dynamic stretches for several weeks. Researchers wi…
Sponsor: University of Lahore • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Head-to-Head: which drug tames facial nerve pain better?
Symptom relief OngoingThis study compares carbamazepine and oxcarbazepine, two drugs used to treat trigeminal neuralgia, a condition causing severe facial pain. Researchers will enroll 122 adults aged 18-60 who have had the condition for at least two weeks. They will measure pain relief using a standa…
Sponsor: Abbasi Shaheed Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Green light therapy: a new hope for chronic pain sufferers?
Symptom relief OngoingThis study tests whether daily exposure to green LED light can reduce chronic pain. 55 adults with conditions like fibromyalgia or nerve pain will use a green or white light device at home for 2 hours each day over 3 months. Researchers will measure changes in pain levels, medica…
Sponsor: University of Arizona • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New spinal device offers hope for diabetic leg pain
Symptom relief By invitation onlyThis study tests a new way of using spinal cord stimulation to treat long-lasting leg pain caused by diabetic nerve damage. Up to 25 adults with severe pain will first try a temporary device, and if it helps, they can get a permanent implant. The main goal is to see if this appro…
Sponsor: TriCity Research Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Face mask zaps nerve pain: new hope for trigeminal neuralgia?
Symptom relief OngoingThis study tests a precise radiation treatment for trigeminal neuralgia, a condition that causes severe facial pain. Instead of a metal frame screwed into the skull, a special face mask holds the head still while x-rays target the painful nerve. The trial includes 40 adults whose…
Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Brain wave therapy may ease chemo nerve pain
Symptom relief OngoingThis study tests whether neurofeedback training—a non-invasive therapy that uses brain wave monitoring—can help people with chemotherapy-induced peripheral neuropathy (nerve pain, numbness, or tingling) learn to change their own brain activity to feel less pain and improve qualit…
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Magnetic pulses to the brain may soothe chemo nerve damage
Symptom relief OngoingThis study tests if a non-invasive treatment called repetitive transcranial magnetic stimulation (rTMS) can reduce nerve pain caused by oxaliplatin chemotherapy in people with stage I-IV cancer. rTMS uses magnetic pulses on the scalp to change brain activity. The trial includes 5…
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New wrap may shield nerves during second elbow surgery
Symptom relief OngoingThis study looks at whether a special nerve wrap can help people who need a second surgery for cubital tunnel syndrome, a condition where a nerve in the elbow gets compressed. Twenty adults with ongoing pain or numbness after their first surgery will receive the nerve protector d…
Sponsor: Axogen Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New combo therapy aims to ease leg swelling in nerve disorder patients
Symptom relief OngoingThis study tests whether combining two non-invasive therapies—infrared light (MIRE) and electrical nerve stimulation (TENS)—can reduce leg swelling caused by nerve-related blood flow problems. About 1000 adults with lower leg swelling took part. The main goal is to see if the tre…
Sponsor: American Association of Sensory Electrodiagnostic Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Desperate patient gets own stem cells for rare nerve disease
Symptom relief Expanded access (ended)This study treated one 58-year-old man with polyneuropathy caused by POEMS syndrome using his own fat-derived stem cells. He received eight infusions over 28 weeks to try to relieve nerve symptoms. The study is no longer available and was not a formal clinical trial.
Sponsor: Hope Biosciences Research Foundation • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Could body fat ease carpal tunnel pain? new study investigates
Symptom relief PausedThis study tests whether injecting a patient's own fat (lipografting) into the wrist can improve symptoms of mild to moderate carpal tunnel syndrome better than standard steroid injections. The fat is thought to reduce scarring and help nerves glide more freely. The trial plans t…
Early phase 1 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Can a natural supplement soothe chemo nerve damage?
Symptom relief OngoingThis phase II trial tests whether a natural supplement called PEA can relieve nerve pain, numbness, and tingling caused by chemotherapy in cancer patients. About 88 adults who have had nerve symptoms for at least 3 months after chemo will take PEA or a placebo for 8 weeks. The st…
Phase 2 • Sponsor: Academic and Community Cancer Research United • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Baking soda in numbing shots could ease carpal tunnel surgery pain
Symptom relief OngoingThis study tests whether adding sodium bicarbonate (baking soda) to the local anesthetic used during carpal tunnel release surgery reduces the pain of the injection itself. 116 adults with carpal tunnel syndrome will be randomly assigned to receive either buffered or standard ane…
Sponsor: Kuopio University Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 18:40 UTC
-
Which stitch leaves a better scar after carpal tunnel surgery?
Symptom relief OngoingThis study compares two common types of stitches used to close the wound after carpal tunnel release surgery: absorbable stitches that dissolve on their own and non-absorbable stitches that need to be removed. About 116 patients will be randomly assigned to one stitch type, and t…
Sponsor: Kuopio University Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 18:34 UTC
-
Can a posture device replace surgery for cubital tunnel syndrome?
Symptom relief PausedThis study tests whether the UpRight Go posture trainer, a wearable device that vibrates when you slouch, can reduce pain, numbness, and weakness in people with cubital tunnel syndrome who haven't had surgery. Researchers at Yale University plan to enroll 40 adults and track symp…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 26, 2026 17:38 UTC
-
Zapping away chemo pain: new device trial offers hope
Symptom relief By invitation onlyThis study tests a non-invasive brain stimulation technique called prolonged continuous theta burst stimulation (pcTBS) to relieve nerve pain caused by chemotherapy in breast cancer patients. Forty women will receive either pcTBS or standard repetitive transcranial magnetic stimu…
Sponsor: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation • Aim: Symptom relief
Last updated Jun 26, 2026 15:44 UTC
-
Light therapy tested for Post-Mastectomy nerve pain – but study never started
Symptom relief CancelledThis study planned to test photobiomodulation (a type of light therapy) on nerve pain and sensation in one woman after mastectomy. The treatment used red and near-infrared light on the affected area for six weeks. However, the study was withdrawn before any participants enrolled,…
Sponsor: Tufts University • Aim: Symptom relief
Last updated Jun 26, 2026 14:31 UTC
-
Can simple nerve stretches ease diabetic burning pain?
Symptom relief By invitation onlyThis study tests two types of nerve stretches—active (patient-controlled) and passive (therapist-applied)—to see which better reduces burning pain, improves muscle strength, and increases joint movement in people with diabetic neuropathy. Sixty adults aged 40 to 65 with diabetes …
Sponsor: Dow University of Health Sciences • Aim: Symptom relief
Last updated Jun 26, 2026 12:43 UTC
-
Can a new questionnaire capture life with hereditary amyloidosis?
Knowledge-focused CancelledResearchers in Argentina are developing and testing a self-administered questionnaire to measure how hereditary transthyretin amyloidosis affects patients' physical, emotional, and social quality of life. The study includes input from neurologists, a cardiologist, a psychologist,…
Sponsor: Hospital General de Niños Pedro de Elizalde • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Nerve pain in diabetes: new study to measure its real impact on daily life
Knowledge-focused OngoingThis study is looking at how nerve pain (neuropathic pain) affects the ability to care for oneself and overall quality of life in people with type 2 diabetes. Researchers will measure pain levels and quality of life in 128 adults with type 2 diabetes. The goal is to better unders…
Sponsor: Bilecik Seyh Edebali Universitesi • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can wearable sensors and walking tests reliably track nerve damage?
Knowledge-focused OngoingResearchers are checking whether tests of muscle strength, walking, balance, and fine motor skills give consistent results in people with polyneuropathy. About 520 adults with various forms of nerve damage, plus healthy volunteers, take part. Participants complete physical tests,…
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Thousands tracked after carpal tunnel surgery: does new device deliver?
Knowledge-focused OngoingThis study is tracking 2000 adults with carpal tunnel syndrome who are having surgery to release the nerve. The surgery uses a special device called UltraGuideCTR, which is guided by ultrasound. Researchers are collecting real-world data on symptoms and hand function for up to 24…
Sponsor: Sonex Health, Inc. • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Massive study aims to unlock secrets of childhood nerve and muscle diseases
Knowledge-focused OngoingThis long-term study looks at children and adults with inherited nerve and muscle disorders that start early in life, like muscular dystrophy. Researchers will track symptoms over time and collect genetic samples from affected individuals, their family members, and healthy volunt…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
ICU walking recovery predictor tested in small study
Knowledge-focused OngoingThis study looks at 25 ICU patients who were on breathing machines for at least 2 days. Researchers want to see if a physical test called CPAx, done when leaving the ICU, can predict how well they walk 3 months later. The goal is to help doctors plan better rehab for patients aft…
Sponsor: Centre Hospitalier Intercommunal Elbeuf-Louviers-Val de Reuil • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Scientists track rare eye disease to uncover clues for future treatments
Knowledge-focused OngoingThis study follows 46 people with gyrate atrophy, a rare genetic condition that causes vision loss, over 4 years. Researchers measure ornithine levels in the blood and track changes in the retina using eye scans and photos. The goal is to learn how the disease progresses under st…
Sponsor: Jaeb Center for Health Research • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Smartwatch could spot nerve damage before it starts
Knowledge-focused CancelledThis study follows women with early-stage breast cancer who are about to receive paclitaxel chemotherapy, a treatment that often causes nerve damage. Researchers will use smartwatches and a mobile app to track physical activity, sleep, and stress, alongside clinical exams and ski…
Sponsor: Theodoros Foukakis • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Blood marker may predict nerve damage onset in rare genetic disease
Knowledge-focused OngoingThis observational study is looking at a protein called neurofilament light chain (NfL) in the blood of people who carry a gene variant for hereditary ATTR amyloidosis, both those without symptoms and those with nerve damage. Researchers want to see if NfL levels can help detect …
Sponsor: Alnylam Pharmaceuticals • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Smart sensors could predict falls in older adults with dizziness
Knowledge-focused By invitation onlyThis study evaluates a sensor-based version of the Timed Up and Go test (QTUG) for measuring balance and predicting fall risk in older adults with dizziness (vestibulopathy). Researchers will compare QTUG results with other balance tests, track whether a six-month vestibular reha…
Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Gene Editing's lasting impact: a Long-Term look at NTLA-2001
Knowledge-focused By invitation onlyThis study follows people who previously received NTLA-2001, an experimental gene-editing therapy, for a type of amyloidosis that can affect nerves or the heart. The goal is to monitor long-term safety and see if the therapy's effects on disease markers persist over time. Partici…
Sponsor: Intellia Therapeutics • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Can a decade of real-world data refine treatment for rare bile acid disorders?
Knowledge-focused OngoingThis study is a patient registry that will follow people of any age with bile acid synthesis disorders who are treated with Cholbam (cholic acid). The goal is to collect information over 10 years on how the drug performs in routine clinical care, including its safety, effectivene…
Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
New study tracks Real-World safety of TEGSEDI for rare nerve disease
Knowledge-focused OngoingThis study follows 240 patients with hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN) to monitor the long-term safety of the drug TEGSEDI. Researchers will compare patients who have taken TEGSEDI with those who have not, focusing on side effects like low platel…
Sponsor: Akcea Therapeutics • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Could spinal cord stimulation help repair nerves in small fiber neuropathy?
Knowledge-focused By invitation onlyThis pilot study looks at whether spinal cord stimulation can improve nerve health in people with small fiber neuropathy, a condition that causes chronic pain. Researchers will measure changes in nerve fiber density from skin biopsies taken before and after 12 months of routine c…
Sponsor: TriCity Research Center • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Researchers track rare nerve disease to unlock future treatments
Knowledge-focused OngoingThis study follows 20 people with a rare nerve disease called CMT4J for up to 2 years. Researchers will track symptoms and health changes to better understand how the disease progresses. The goal is to find better ways to measure the disease, which could help design future treatm…
Sponsor: Elpida Therapeutics SPC • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Leg stretch may alter nerve pain sensitivity, tiny study hints
Knowledge-focused By invitation onlyThis study tests whether a specific leg stretching technique, called sciatic nerve mobilization, can change how sensitive the nerves in your lower leg are to pressure pain. 34 healthy university students will either receive the stretch or no treatment. Researchers will measure pa…
Sponsor: Fenerbahce University • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Flat feet may be tied to a common cause of hip pain, study suggests
Knowledge-focused OngoingThis study looks at whether people with flat feet (pes planus) are more likely to have piriformis syndrome, a condition that causes pain in the hip and lower back. Researchers will compare foot posture and pain in adults aged 18-65 who have piriformis syndrome with those who do n…
Sponsor: Kahramanmaras Sutcu Imam University • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Zapped nerves: study planned to boost recovery after surgery — but never started
Knowledge-focused CancelledThis study was designed to see if giving a short, mild electrical stimulation to compressed nerves during surgery could speed up recovery of strength and function. It planned to include people with nerve compression in the spine or limbs who were already scheduled for decompressi…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Major study launches to unravel the Real-World impact of rare nerve disease
Knowledge-focused OngoingThis study follows about 413 adults with multifocal motor neuropathy (MMN) over time to learn how the disease progresses and affects daily life. Researchers will collect information on symptoms, quality of life, and healthcare use during regular doctor visits. No experimental tre…
Sponsor: argenx • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Hidden heart risk in kids with diabetes: new study investigates
Knowledge-focused OngoingThis study examines how common cardiac autonomic neuropathy (nerve damage affecting the heart) is in children and teens with type 1 diabetes. Researchers will monitor 75 participants using heart tests and check if longer diabetes duration or poor blood sugar control raises the ri…
Sponsor: Marwa Abouelela Abd Elsalam • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New study aims to perfect how we measure muscle recovery in ICU survivors
Knowledge-focused OngoingThis study looks at whether a tool called the Chelsea Critical Care Physical Assessment tool (CPAx) can accurately track recovery in 120 adults who developed muscle weakness after being on a breathing machine in the ICU. The goal is to find the smallest meaningful improvement tha…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Brain monitor may guide safer blood pressure during surgery
Knowledge-focused OngoingThis study looks at whether low blood pressure during major noncardiac surgery harms organs like the heart and kidneys. Researchers are using a non-invasive brain monitor to see if a personalized blood pressure target can be set. 650 patients at cardiovascular risk are being obse…
Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Blood pressure clues may predict early death after heart attack
Knowledge-focused OngoingThis study examines whether a low pulse pressure (the difference between top and bottom blood pressure numbers) in the first hours after a cardiac arrest is linked to early death. Researchers will analyze data from 3500 patients who had a cardiac arrest outside the hospital and a…
Sponsor: Region Skane • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Sugar water injection may reveal hidden strength in drop foot patients
Knowledge-focused By invitation onlyThis study looks at whether a simple injection of sugar water (D5W) can reliably bring out a hidden sign of muscle strength in people with drop foot. Researchers will inject the fluid under the skin and check muscle strength before and after. The goal is to see if this test can h…
Sponsor: US Neuropathy Centers • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Med student stress may be tied to wrist pain, new study suggests
Knowledge-focused By invitation onlyThis study looks at whether anxiety and depression are connected to carpal tunnel syndrome in medical students. Researchers will measure the median nerve in the wrist and check students' anxiety and depression levels using questionnaires. The goal is to see if there is a link bet…
Sponsor: University of Ioannina • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Pandemic's toll on cancer patients with neuropathy under the microscope
Knowledge-focused OngoingThis study looks at how the COVID-19 pandemic impacted the quality of life of 274 cancer patients who also have neuropathy (nerve pain). All participants had taken part in earlier clinical trials. Researchers want to see if there are differences between those who received a brain…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
New study aims to catch diabetic nerve damage earlier
Knowledge-focused By invitation onlyThis study will measure nerve signals in 50 adults aged 45 to 76 with diabetic peripheral neuropathy. Researchers will compare these signals with blood sugar levels, diabetes duration, and neuropathy symptom scores. The goal is to find better ways to detect nerve damage early.
Sponsor: Fenerbahce University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Decision aids may ease patient uncertainty in hand surgery
Knowledge-focused PausedThis study tests whether giving patients with hand problems like carpal tunnel syndrome or trigger finger a decision aid—a booklet with clear information about their condition and treatment options—helps them feel more satisfied and less conflicted about their choices. About 126 …
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Can a simple scale accurately measure hand problems in carpal tunnel syndrome?
Knowledge-focused By invitation onlyThis study is checking whether a questionnaire called the MAP-Hand scale is a valid and reliable way to measure hand activity in people with carpal tunnel syndrome. Researchers will enroll 180 adults with mild or moderate carpal tunnel syndrome and compare their scale results to …
Sponsor: Kirsehir Ahi Evran Universitesi • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Scientists probe brain changes behind chronic pain
Knowledge-focused OngoingThis study looks at how the nervous system becomes overly sensitive in people with different types of chronic pain. Researchers will assess 185 adults using questionnaires, thinking tests, and laser brain-wave measurements at the start and after one year. The goal is to better un…
Sponsor: IRCCS Centro Neurolesi Bonino Pulejo • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
Brain wave study on ketamine for pain withdrawn before starting
Knowledge-focused CancelledThis study was designed to observe brain wave (EEG) changes in adults with chronic neuropathic pain during ketamine treatment. Researchers hoped to find patterns that could predict which patients benefit most. However, the study was withdrawn before enrolling any participants, so…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Brain training with mirrors and zaps: new hope for nerve injury recovery?
Knowledge-focused OngoingThis study looks at how combining mirror therapy, electrical stimulation, and motor imagery changes brain activity in people with recent forearm nerve injuries and in healthy adults. Researchers want to understand if these therapies can help the brain adapt better after injury. T…
Sponsor: Chang Gung Memorial Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
ICU physiotherapy under the microscope: can we measure its true cost?
Knowledge-focused OngoingThis study looks at how much energy critically ill patients on ventilators use during routine passive physiotherapy. By measuring oxygen consumption with a special device in the breathing tube, researchers hope to understand the physical demands of these exercises. The goal is to…
Sponsor: Universidad de Extremadura • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
New study seeks to predict muscle weakness in ICU kids before it strikes
Knowledge-focused By invitation onlyThis study aims to find early biological markers that can predict muscle weakness in children who need a breathing machine in the intensive care unit. About 500 children will be observed to see who develops this condition. The goal is to create a warning system so doctors can int…
Sponsor: Children's Hospital of Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
New study aims to predict muscle weakness in kids on ventilators before it strikes
Knowledge-focused By invitation onlyThis study is developing an early warning model to predict ICU-acquired weakness in children who need mechanical ventilation. Researchers will track 1,500 children in the PICU, looking for biomarkers and other signs that could forecast muscle weakness. The goal is to move from di…
Sponsor: Children's Hospital of Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
New study aims to catch brain damage in babies after heart surgery
Knowledge-focused By invitation onlyThis study follows 30 infants with congenital heart disease who need heart surgery. Researchers will use blood tests, EEG brain wave monitoring, and MRI scans to look for signs of brain injury. The goal is to find better ways to detect brain damage early and identify which childr…
Sponsor: University Medical Centre Ljubljana • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Stitch showdown: which suture leaves a better scar after hand surgery?
Knowledge-focused CancelledThis study aimed to see if using stitches that dissolve (absorbable) or stitches that need removal (non-absorbable) leads to better scar appearance and patient satisfaction after carpal tunnel or trigger finger surgery. It was planned for adults having these common hand surgeries…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
AI and VR join forces to fight severe facial pain
Knowledge-focused By invitation onlyThis study looks at people with trigeminal neuralgia, a condition that causes severe facial pain. Researchers want to see if adding virtual reality (VR) training before Gamma Knife surgery can improve pain relief. They will also use artificial intelligence (AI) and brain scans to…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Eye pain mystery: scientists probe nerve link in dry eye sufferers
Knowledge-focused PausedThis study looks at how common nerve problems are in people who feel eye discomfort. Researchers will test 1,000 participants to see if their pain is linked to nerve damage rather than just dry eye. The goal is to better understand these conditions and improve diagnosis.
Sponsor: Tufts Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New ultrasound could better track carpal tunnel recovery
Knowledge-focused By invitation onlyThis study tests a new ultrasound technique called shear wave elastography to measure stiffness in the wrist nerves and tissues of people with carpal tunnel syndrome. Researchers will compare these measurements with standard tests before and after treatment (surgery or steroid in…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New eye test could unlock secrets of ocular pain
Knowledge-focused PausedThis study looks at how well a new test called quantitative sensory testing (QST) can measure nerve function in the eye. Researchers will use heat, cold, and vibration to see how people with dry eye disease or corneal nerve damage respond. The goal is to better understand eye pai…
Sponsor: Tufts Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Massive gene hunt launched for mysterious mitochondrial diseases
Knowledge-focused By invitation onlyThis study aims to discover new genetic mutations that cause mitochondrial disorders by analyzing tissue samples from up to 6,900 participants. It includes people with suspected or known mitochondrial diseases, such as MELAS or Leigh's Disease, who lack a genetic diagnosis. The r…
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Heart check: do Nerve-Targeting drugs also shield the heart in rare amyloidosis?
Knowledge-focused OngoingThis study follows 20 adults with hereditary transthyretin amyloidosis (ATTRv) who have both nerve and heart involvement. They are treated with patisiran or vutrisiran for two years. Researchers use MRI scans and questionnaires to see how the drugs affect heart structure and func…
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Researchers probe hidden jaw pain in nerve disorder patients
Knowledge-focused CancelledThis study aimed to find out how many people with trigeminal neuralgia (a severe facial nerve pain condition) also have temporomandibular disorder (TMD), which causes jaw pain. Researchers planned to follow patients from three clinics and test a questionnaire to better diagnose b…
Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
New pathway aims to cut wait times for carpal tunnel patients
Knowledge-focused By invitation onlyThis study looks at whether a new care pathway can shorten wait times for people with carpal tunnel syndrome. Researchers will compare wait times before and after the pathway is put in place. About 200 adults will take part and fill out a short satisfaction survey.
Sponsor: University of British Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Night pain in knee OA linked to nerve pain, study suggests
Knowledge-focused By invitation onlyThis study looks at 150 people with knee osteoarthritis to see how often night pain and nerve pain (neuropathic pain) occur together. Researchers will use questionnaires and physical exams to measure pain and sleep quality. The goal is to better understand these pain types and th…
Sponsor: Bozyaka Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC